Inventor · disambiguated record
Igor Mett
Also filed as: METT IGOR
44 granted patents·28 pending applications·505 citations·filing 1995–2018
98Inventor score
Files withFEINSTEIN ELENA18QUARK PHARMACEUTICALS INC17YEDA RES & DEV16NITTO DENKO CORP6AVKIN-NACHUM SHARON3
Top patents by PatentIndex Score
72 records- 0199US7626015B2Therapeutic uses of inhibitors of RTP801LQUARK PHARMACEUTICALS INC·Filed 2007·Granted Dec 1, 2009·113 cites·6 claims
- 0295US9932578B2Double-stranded oligonucleotide molecules to P53 and methods of use thereofQUARK PHARMACEUTICALS INC·Filed 2013·Granted Apr 3, 2018·31 cites·9 claims
- 0395US8741867B2Retinoid-liposomes for treating fibrosisNIITSU YOSHIRO·Filed 2012·Granted Jun 3, 2014·34 cites·29 claims
- 0495US8664376B2Retinoid-liposomes for enhancing modulation of HSP47 expressionNIITSU YOSHIRO·Filed 2012·Granted Mar 4, 2014·30 cites·26 claims
- 0593US10196637B2Retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·7 cites·20 claims
- 0693US9206424B2Modulation of HSP47 expressionNITTO DENKO CORP·Filed 2014·Granted Dec 8, 2015·21 cites·33 claims
- 0792US9121020B2Methods for treating eye disordersQUARK PHARMACEUTICALS INC·Filed 2014·Granted Sep 1, 2015·20 cites·23 claims
- 0890US8710209B2Modulation of HSP47 expressionJIN XIAOMEI·Filed 2010·Granted Apr 29, 2014·22 cites·37 claims
- 0990US8017764B2Therapeutic uses of inhibitors of RTP801LQUARK PHARMACEUTICALS INC·Filed 2009·Granted Sep 13, 2011·10 cites·8 claims
- 1089US9456984B2Method for treating fibrosis using siRNA and a retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2014·Granted Oct 4, 2016·10 cites·58 claims
- 1189US7101675B2Modulators of regulatory proteinsYEDA RES & DEV·Filed 2002·Granted Sep 5, 2006·18 cites·21 claims
- 1289US6602993B2DNA molecule encoding TNF binding ligands and vectors and host cells containing the DNA moleculeYEDA RES & DEV·Filed 2001·Granted Aug 5, 2003·19 cites·4 claims
- 1388US8614309B2Double-stranded RNA directed to CASP2 and methods of use thereofFEINSTEIN ELENA·Filed 2008·Granted Dec 24, 2013·11 cites·34 claims
- 1488US6555111B2Method of inhibiting the cytocidal effect of TNF with TNF receptor-specific antibodiesYEDA RES & DEV·Filed 2001·Granted Apr 29, 2003·16 cites·3 claims
- 1586US10093923B2Modulation of HSP47 expressionNITTO DENKO CORP·Filed 2015·Granted Oct 9, 2018·5 cites·35 claims
- 1685US10195145B2Method for treating fibrosis using siRNA and a retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·4 cites·31 claims
- 1785US8278287B2siRNA compounds for inhibiting NRF2FEINSTEIN ELENA·Filed 2009·Granted Oct 2, 2012·5 cites·21 claims
- 1882US6579697B1Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptorsYEDA RES & DEV·Filed 1996·Granted Jun 17, 2003·32 cites·14 claims
- 1981US9701961B2Methods for treating eye disordersQUARK PHARMACEUTICALS INC·Filed 2015·Granted Jul 11, 2017·3 cites·20 claims
- 2080US8614311B2RTP801L siRNA compounds and methods of use thereofQUARK PHARMACEUTICALS INC·Filed 2012·Granted Dec 24, 2013·2 cites·19 claims
- 2179US6262239B1TNF receptor-specific antibodiesYEDA RES & DEV·Filed 1995·Granted Jul 17, 2001·29 cites·5 claims
- 2278US9222087B2Therapeutic uses of inhibitors of RTP801LFEINSTEIN ELENA·Filed 2013·Granted Dec 29, 2015·2 cites·7 claims
- 2376US7186682B2Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptorsYEDA RES & DEV·Filed 2003·Granted Mar 6, 2007·4 cites·4 claims
- 2475US10421962B2Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereofQUARK PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·1 cites·6 claims
- 2575US6232446B1TNF ligandsYEDA RES & DEV·Filed 1995·Granted May 15, 2001·33 cites·15 claims
- 2674US8236507B2Modulators of TNF receptor associated factor (TRAF), their preparation and useWALLACH DAVID·Filed 2009·Granted Aug 7, 2012·2 cites·9 claims
- 2773US9611474B2Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereofQUARK PHARMACEUTICALS INC·Filed 2013·Granted Apr 4, 2017·1 cites·20 claims
- 2872US9205100B2Compositions and methods for treating lung disease and injuryGELMAN ANDREW E·Filed 2012·Granted Dec 8, 2015·3 cites·6 claims
- 2972US8765931B2Double-stranded oligonucleotide compound for down-regulating the expression of CASP2 geneFEINSTEIN ELENA·Filed 2009·Granted Jul 1, 2014·1 cites·9 claims
- 3072US7723052B2Screening systems utilizing RTP801QUARK PHARMACEUTICALS INC·Filed 2007·Granted May 25, 2010·3 cites·18 claims
- 3171US9822362B2Compositions and methods for treating lung disease and injuryQUARK PHARMACEUTICALS INC·Filed 2015·Granted Nov 21, 2017·1 cites·19 claims
- 3271US8344104B2Screening systems utilizing RTP801QUARK PHARMACEUTICALS INC·Filed 2011·Granted Jan 1, 2013·1 cites·5 claims
- 3370US9045755B2Double stranded RNA compounds to RhoA and use thereofAVKIN-NACHUM SHARON·Filed 2011·Granted Jun 2, 2015·1 cites·9 claims
- 3469US8034575B2Screening systems utilizing RTP801QUARK PHARMACEUTICALS INC·Filed 2010·Granted Oct 11, 2011·1 cites·18 claims
- 3568US9487778B2Oligonucleotide modulators of the toll-like receptor pathwayFEINSTEIN ELENA·Filed 2012·Granted Nov 8, 2016·1 cites·16 claims
- 3667US7323548B2Modulators of the function of FAS/APO1 receptorsYEDA RES & DEV·Filed 2004·Granted Jan 29, 2008·0 cites·9 claims
- 3764US7455977B2Methods of determining the level of human TBP-II with anti-TBP-II antibodyYEDA RES & DEV·Filed 2003·Granted Nov 25, 2008·0 cites·2 claims
- 3864US2009162365A1Novel siRNAS and methods of use thereofFEINSTEIN ELENA·Filed 2007·Application pending·0 cites
- 3962US2010273854A1Compositions and methods for inhibiting nadph oxidase expressionKALINSKI HAGAR·Filed 2008·Application pending·0 cites
- 4060US2009156524A1Novel siRNAS and methods of use thereofFEINSTEIN ELENA·Filed 2008·Application pending·0 cites
- 4160US2003228312A1TNF receptor-specific antibodiesYEDA RES & DEV·Filed 2003·Application pending·0 cites
- 4259US2009214575A1Annexin II and uses thereofFEINSTEIN ELENA·Filed 2008·Application pending·0 cites
- 4359US2007232520A1Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptorsYEDA RES & DEV·Filed 2006·Application pending·0 cites
- 4458US2014350068A1Rtp801l sirna compounds and methods of use thereofFEINSTEIN ELENA·Filed 2013·Application pending·0 cites
- 4557US6808891B2Modulators of the function of FAS/APO1 receptorsYEDA RES & DEV·Filed 2001·Granted Oct 26, 2004·0 cites·6 claims
- 4657US2007166787A1Modulators of regulatory proteinsYEDA RES & DEV·Filed 2006·Application pending·0 cites
- 4756US2013267578A1Compositions and methods for inhibiting nadph oxidase expressionKALINSKI HAGAR·Filed 2013·Application pending·0 cites
- 4856US2012108647A1Therapeutic uses of inhibitors of rtp801lFEINSTEIN ELENA·Filed 2011·Application pending·0 cites
- 4955US2017306329A1Methods for treating eye disordersQUARK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 5054US2002082401A1Modulators of the function of FAS/APO1 receptorsYEDA RES AND DEV COMPANY·Filed 2001·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Igor Mett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →